See also this year's filing and all EDGAR filings for this company.
PDF Report 0001082554_2011_United_Therapeutics_Corp.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001082554, United Therapeutics Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 764,487,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 306,044,000 |
| 3 | remainder_Assets | 361,104,000 |
| 4 | LiabilitiesCurrent | 428,686,000 |
| 5 | LiabilitiesNoncurrent | 39,252,000 |
| 6 | remainder_Liabilities | 68,929,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 199,600,000 |
| 9 | ResearchAndDevelopmentExpense | 166,761,000 |
| 10 | remainder_Expenses | 115,388,000 |
| 11 | remainder_Revenues | 603,831,000 |
| 12 | remainder_NetIncome | -16,166,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,431,635,000 |
| 1 | Liabilities | 536,867,000 |
| 2 | Expenses | 481,749,000 |
| 3 | Revenues | 603,831,000 |
| 4 | StockholdersEquity | 894,768,000 |
| 5 | NetIncome | 105,916,000 |
| 6 | ComprehensiveNetIncome | 105,916,000 |
| 7 | BaseVar | 1,535,124,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.09 |
| 9 | EconomicCapitalRatio | 3.08 |
Edgar->Model Mapping
Feature Distribution
